Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Effect of chronic treatment with trandolapril or enalapril on brain ACE activity in spontaneously hypertensive rats.

Jouquey S, Mathieu MN, Hamon G, Chevillard C.

Neuropharmacology. 1995 Dec;34(12):1689-92.

PMID:
8788966
2.

Trandolapril dose-response in spontaneously hypertensive rats: effects on ACE activity, blood pressure, and cardiac hypertrophy.

Jouquey S, Stepniewski JP, Hamon G.

J Cardiovasc Pharmacol. 1994;23 Suppl 4:S16-8.

PMID:
7527096
3.

Compared properties of trandolapril, enalapril, and their diacid metabolites.

Chevillard C, Jouquey S, Bree F, Mathieu MN, Stepniewski JP, Tillement JP, Hamon G, Corvol P.

J Cardiovasc Pharmacol. 1994;23 Suppl 4:S11-5.

PMID:
7527095
4.

Effects of subchronic treatment with trandolapril and enalapril on cardiovascular morphologic alterations in the aged spontaneously hypertensive rat with heart failure.

Secchi J, Lecaque D, Dunn FW, Jouquey S, Auberval UD, Benzoni F, Sirugue O, Hamon G.

J Cardiovasc Pharmacol. 1994;23 Suppl 4:S30-7.

PMID:
7527099
5.

Angiotensin-converting enzyme inhibition, anti-hypertensive activity and hemodynamic profile of trandolapril (RU 44570).

Brown NL, Badel MY, Benzoni F, Zanirato J, Vincent JC, Fichelle J, Worcel M.

Eur J Pharmacol. 1988 Mar 22;148(1):79-91.

PMID:
3383998
6.

Differential effects of oral trandolapril and enalapril on rat tissue angiotensin-converting enzyme.

Chevillard C, Brown NL, Mathieu MN, Laliberté F, Worcel M.

Eur J Pharmacol. 1988 Feb 16;147(1):23-8.

PMID:
2836219
7.

Cardiovascular actions and tissue-converting enzyme inhibitory effects of chronic enalapril and trandolapril treatment of spontaneously hypertensive rats.

Chevillard C, Brown NL, Jouquey S, Mathieu MN, Laliberté F, Hamon G.

J Cardiovasc Pharmacol. 1989 Aug;14(2):297-301.

PMID:
2476605
9.
10.

Trandolapril reduces infarction area after middle cerebral artery occlusion in rats.

Okamoto K, Takai S, Sasaki S, Miyazaki M.

Hypertens Res. 2002 Jul;25(4):583-8.

11.

Vascular affinity of trandolapril.

Miyazaki M, Kawamoto T, Okunishi H.

Am J Hypertens. 1995 Oct;8(10 Pt 2):63S-67S. Review.

PMID:
8845086
13.

Antinociceptive effects of angiotensin-converting enzyme inhibitors and an angiotensin II receptor antagonist in mice.

Takai S, Song K, Tanaka T, Okunishi H, Miyazaki M.

Life Sci. 1996;59(21):PL331-6.

PMID:
8937511
15.
16.

Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors?

Raasch W, Bartels T, Schwartz C, Häuser W, Rütten H, Dominiak P.

J Hypertens. 2002 Dec;20(12):2495-504.

PMID:
12473875
17.

Chronic ACE inhibition by quinapril modulates central vasopressinergic system.

Muders F, Elsner D, Jandeleit K, Bahner U, Kromer EP, Kirst I, Riegger GA, Palkovits M.

Cardiovasc Res. 1997 Jun;34(3):575-81.

18.

Inhibition of matrix metalloproteinase-9 activity by trandolapril after middle cerebral artery occlusion in rats.

Tanaka H, Takai S, Jin D, Furubayashi K, Inoue N, Kajimoto Y, Miyatake S, Kuroiwa T, Miyazaki M.

Hypertens Res. 2007 May;30(5):469-75.

PMID:
17587759
19.

Duration of inhibition of local microvascular ACE in spontaneously hypertensive rats.

Vicaut E, Hou X.

J Hypertens. 1995 Dec;13(12 Pt 2):1758-63.

PMID:
8903647
20.

Beneficial effect of trandolapril on the lifespan of a severe hypertensive model.

Takai S, Sakonjo H, Miyazaki M.

Hypertens Res. 2001 Sep;24(5):559-64.

Items per page

Supplemental Content

Write to the Help Desk